Recruiting at 1 site No phase Cardiac Arrhythmia

Cardiac Arrhythmia study: HeartWatch

Official title Cardiac Arrhythmia Telemetry; Conventional vs HeartWatch

ClinicalTrials.gov ID: NCT06164808

What this study is testing

What it's testing
The study wants to see if the HeartWatch device can detect arrhythmias better or longer than the usual monitoring methods.
Who it's for
Adults who have been diagnosed with atrial fibrillation, atrial flutter, supraventricular tachycardia, bradycardia, pauses, or ventricular arrhythmias.
What's involved
Participants will wear the HeartWatch on their upper arm and use a smartphone app to record symptoms. They will also receive the standard telemetry monitoring used in hospitals or clinics.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 22 and older

You may be able to join if

  • At least 22 years of age at time of consent
  • Clinically indicated for a Holter monitor test
  • Able to wear the HeartWatch on the left bicep for the study duration
  • Able to follow the protocol
  • No functional implantable pacemaker or defibrillator

You likely can't join if

  • Known allergy to any component of the Holter monitor
  • Known allergy to any component of the HeartWatch
  • Inability to wear the HeartWatch on the left arm for the study period due to pre-existing medical condition (3.g., functional AV fistula in left arm...
  • Dextrocardia
  • Implanted functional Pacemaker or Defibrillator
  • Left bicep circumference \< 22 cm
See the full eligibility criteria
Who can join
  • At least 22 years of age at time of consent
  • Clinically indicated for a Holter monitor test
  • Able to wear the HeartWatch on the left bicep for the study duration
  • Able to follow the protocol
  • No functional implantable pacemaker or defibrillator
  • Left bicep circumference \>/= 22 cm and \</= 45 cm
  • Provision of written-informed consent
What rules you out
  • Known allergy to any component of the Holter monitor
  • Known allergy to any component of the HeartWatch
  • Inability to wear the HeartWatch on the left arm for the study period due to pre-existing medical condition (3.g., functional AV fistula in left arm, prior carcinoma with lymph node dissection or lymphedema, known blood...
  • Dextrocardia
  • Implanted functional Pacemaker or Defibrillator
  • Left bicep circumference \< 22 cm
  • Left bicep circumference \< 45 cm

The study team makes the final eligibility decision.

Where it is enrolling

  • Calgary, Alberta, Canada

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 22 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Calgary, Alberta, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.